Please assess the completion status of the following clinical trial:

Trial Title: Effectivity of Postpartum Dexamethasone for Women With Class I HELLP Syndrome

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Postpartum women with Class I HELLP syndrome~Exclusion Criteria:~* Chronic users of corticosteroids~* Patients with chronic conditions affecting the laboratory parameters involved in the HELLP syndrome~* Women who had received antenatal corticosteroids to treat HELLP syndrome were excluded

- Gender: FEMALE
- Minimum Age: 13 Years
- Maximum Age: 49 Years
- Healthy Volunteers: f

Study Arms:
- saline solution (Type: PLACEBO_COMPARATOR): Placebo (saline solution), 2 mL, intravenous, every 12 hours, for 48 hours
- Dexamethasone (Type: ACTIVE_COMPARATOR): Dexamethasone, 10mg (2mL), intravenous, every 12 hours, for 48 hours

Based on this trial design, predict the completion outcome and termination type (if applicable).